• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.66% Nasdaq Up 0.88%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    3.65 Down 0.12(3.18%) 4:00PM EDT
    |After Hours : 3.65 Up 0.00 (0.01%) 4:40PM EDT
    Prev Close:3.77
    Open:3.76
    Bid:3.56 x 1000
    Ask:3.88 x 1000
    1y Target Est:4.00
    Beta:0.785653
    Next Earnings Date: 4-May-16PDLI Earnings announcement
    Day's Range:3.53 - 3.78
    52wk Range:2.58 - 6.93
    Volume:1,698,054
    Avg Vol (3m):2,352,430
    Market Cap:602.67M
    P/E (ttm):1.80
    EPS (ttm):2.03
    Div & Yield:0.20 (5.31%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 3.18%602.67M
    AMGNUp 0.44%119.25B
    XOMADown 0.93%97.62M
    SGENUp 2.51%5.09B

    Key Statistics

    Forward P/E (1 yr):60.83
    P/S (ttm):1.27
    Ex-Dividend Date:02-Mar-16

    Analysts

    Annual EPS Est (Dec-16) :0.66
    Quarterly EPS Est (Mar-16) :0.50
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback